We quantified podoplanin and GFAP staining intensity and calculated the staining intensity ratio, which showed a trend toward a reduction in Pdgfb ret/ret mice treated with PLX5622 (fig.
1
—
—
We quantified podoplanin and GFAP staining intensity and calculated the staining intensity ratio, which showed a trend toward a reduction in Pdgfb ret/ret mice treated with PLX5622 (fig.